Ignite Creation Date:
2024-05-06 @ 4:24 PM
Last Modification Date:
2024-10-26 @ 2:09 PM
Study NCT ID:
NCT04976322
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-07-12
First Post:
2021-07-14
Brief Title:
A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
Sponsor:
Organization:
UCB Pharma